cGMP Manufacture
- All
- APIs
- Aseptic Processing
- cGMP Manufacture
- Cleaning Validation
- Clinical Trial Materials
- Cytotoxics and High Potency Manufacturing
- Excipients
- Extractables and Leachables
- Facilities
- Fill/Finish
- Lyophilization
- Parenterals
- Process Development
- Process Validation
- Risk Management
- Scale-up/Technology Transfer
- Solid Dosage/Creams/Ointments
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Catalent to Acquire Bone Therapeutics’ Cell Therapy Mfg. Facility
Expands cell therapy capabilities and advanced clinical and commercial supply, and creates an integrated European CoE.Contract Pharma Staff 10.29.20
-
Breaking News | cGMP Manufacture | Industry News
Aphena Pharma Completes $7M Facility Expansion
Newly renovated, 30,000-sq.-ft. facility and three large blending suites support liquids, creams, gels and suspensions.Cntract Pharma Staff 10.28.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Parenterals
DOD Awards Ology Vaccine Manufacturing Contract
CDMO to manufacture and test novel live attenuated tularemia vaccine candidate.Contract Pharma Staff 10.28.20
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
3P Biopharmaceuticals and SpyBiotech Enter Vaccine Contract Manufacturing Agreement
Looking towards completing production in 2021.Contract Pharma Staff 10.26.20
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
Roche, Atea Pharma to Develop Potential Oral COVID-19 Treatment
To develop, manufacture and distribute AT-527, Atea’s investigational oral direct-acting antiviral being studied to treat COVID-19.Contract Pharma Staff 10.22.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News | Scale-up/Technology Transfer
Catalent, BrainStorm Enter ALS Drug Manufacturing Pact
Catalent will undertake the transfer of the manufacturing process to, and provide future cGMP clinical supply of NurOwn from its Houston facility.Contract Pharma Staff 10.22.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News | Process Development
ProBioGen, Heidelberg Pharma Ink ATAC Agreement
ProBioGen is conducting cell line development, process development and GMP manufacturing of the mAb intermediates of Heidelberg’s ATAC molecules for cancer.10.22.20
-
Breaking News | cGMP Manufacture | Industry News
Lonza Expands Capsule Mfg. Capacity
$93 million investment to expand production capacity of capsules in CHI's Capsugel portfolio by 30 billion capsules annually, or 15%.10.22.20
-
APIs | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
JSR Life Sciences Expands European Footprint
Will co-locate primary European operations for affiliate companies KBI Biopharma and Selexis SA in Geneva’s ZIPLO campus.10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
CEVEC, Rznomics Ink License Agreement for CAP Technology
Rznomics will use CEVEC’s cell line technology with its trans-splicing ribozyme technology for manufacturing gene therapies targeting various cancers.10.20.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
AstraZeneca, U.S. Govt. Enter $486M COVID-19 Antibody Agreement
Funding will be used for two Phase III trials and related development and manufacturing activities for the supply of AZD7442 doses in the U.S.Contract Pharma Staff 10.16.20
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Facilities | Industry News
GSK to Sell Poznań Manufacturing Site to Delpharm
The CDMO acquires all facilities and gains approximately 700 manufacturing employees.Contract Pharma Staff 10.15.20
-
Breaking News | cGMP Manufacture | Industry News
Recipharm Invests €2.6M in Kaysersberg Facility
The Kaysersberg facility specializes in producing sterile liquids for therapeutic areas including eye care and ear drops.10.14.20
-
cGMP Manufacture | Drug Development | Promotions & Moves
AGC Biologics Appoints New GM of Milan Site
Luca Alberici will initiate integration efforts resulting from the July 2020 acquisition of MolMed.Contract Pharma Staff 10.12.20
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Facilities | Industry News
Abzena Invests $60M Into cGMP Manufacturing Capacity
New facility in San Diego houses a process development laboratory and two new cGMP manufacturing cleanrooms.Contract Pharma Staff 10.08.20
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Recipharm, Arcturus Ink LUNAR-COV19 Vax Mfg. Pact
Recipharm to support the manufacture of ARCT-021, Arcturus’ COVID-19 vaccine candidate that is in an ongoing Phase I/II clinical trial.Contract Pharma Staff 10.07.20
-
Bioanalytical Services | Breaking News | cGMP Manufacture | Industry News
FDA Approves First Drug Using AJIPHASE Production Process
AJIPHASE platform is for the development and cGMP manufacture of high quality and purity commercial quantities of oligonucleotides and peptides.Contract Pharma Staff 10.07.20
-
Breaking News | cGMP Manufacture | Clinical Trial Materials | Industry News
Cobra Biologics to Manufacture Plasmids for COVID-19 Vax Trial
Collaboration will ensure GMP production of material for Phase I clinical trial of Scancell’s DNA vaccine against SARS-CoV-2.Contract Pharma Staff 10.05.20
-
Breaking News | cGMP Manufacture | Formulation Development | Industry News | Scale-up/Technology Transfer
Catalent Launches OneXpress Solution
Aims to accelerate a program’s transition from early-phase development to commercial-ready manufacturing for oral dosage products.Contract Pharma Staff 10.01.20
-
Breaking News | cGMP Manufacture | Industry News | Parenterals | QA/QC
Lonza Expands QC Testing Portfolio
Launches PyroCell MAT System for in vitro Pyrogen testing to help ensure safety of parenteral pharmaceuticals during development, manufacture and release.Contract Pharma Staff 10.01.20
